BioLight Life (Israel) Top Management
| BOLT Stock | ILS 338.40 0.00 0.00% |
BioLight Life employs about 5 people. The company is managed by 18 executives with a total tenure of roughly 146 years, averaging almost 8.0 years of service per executive, having 0.28 employees per reported executive. Analysis of BioLight Life's management performance can provide insight into the company performance.
| Suzana NahumZilberberg CEO CEO |
| Israel Makov Chairman Chairman of the Board |
BioLight |
BioLight Life Management Team Effectiveness
The company has return on total asset (ROA) of (0.0925) % which means that it has lost $0.0925 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0911) %, meaning that it generated substantial loss on money invested by shareholders. BioLight Life's management efficiency ratios could be used to measure how well BioLight Life manages its routine affairs as well as how well it operates its assets and liabilities.BioLight Life Workforce Comparison
BioLight Life Sciences is number one stock in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 91.0. BioLight Life holds roughly 5.0 in number of employees claiming about 5% of equities under Health Care industry.
BioLight Life Sciences Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioLight Life Sciences Price Series Summation is a cross summation of BioLight Life price series and its benchmark/peer.
BioLight Life Notable Stakeholders
A BioLight Life stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioLight Life often face trade-offs trying to please all of them. BioLight Life's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioLight Life's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Suzana NahumZilberberg | CEO | Profile | |
| Israel Makov | Chairman of the Board | Profile | |
| Karin Gurevitz | Vice President General Counsel, Secretary | Profile | |
| Eliahu Hasidim | CFO | Profile | |
| Eliahu Shohet | Director | Profile | |
| Tamar Kfir | External Director | Profile | |
| Yifftach Biel | Finance Director | Profile | |
| Efrat Makov | Director | Profile | |
| Rina Shafir | External Director | Profile | |
| Jran Zhang | Director | Profile | |
| Ron Mayron | Independent Director | Profile | |
| Jacob Faigenbaum | Independent Director | Profile | |
| Yifftach CPA | Chief Officer | Profile | |
| Tali Amar | Controller | Profile | |
| Ronit Gross | CoFounder | Profile | |
| Ron MD | Chief Board | Profile | |
| Yaacov Michlin | Chief Officer | Profile | |
| Ronen Leibovitz | Internal Auditor | Profile |
About BioLight Life Management Performance
The success or failure of an entity such as BioLight Life Sciences often depends on how effective the management is. BioLight Life management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioLight management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioLight management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. BioLight Life Sciences Ltd. was founded in 2005 and is based in Tel Aviv, Israel. BIOLIGHT LIFE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.
The data published in BioLight Life's official financial statements usually reflect BioLight Life's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of BioLight Life Sciences. For example, before you start analyzing numbers published by BioLight accountants, it's critical to develop an understanding of what BioLight Life's liquidity, profitability, and earnings quality are in the context of the Life Sciences Tools & Services space in which it operates.
Please note, the presentation of BioLight Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioLight Life's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in BioLight Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioLight Life Sciences. Please utilize our Beneish M Score to check the likelihood of BioLight Life's management manipulating its earnings.
BioLight Life Workforce Analysis
Traditionally, organizations such as BioLight Life use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioLight Life within its industry.BioLight Life Manpower Efficiency
Return on BioLight Life Manpower
| Revenue Per Employee | 600 | |
| Revenue Per Executive | 167 | |
| Net Income Per Employee | 76.4K | |
| Net Income Per Executive | 21.2K | |
| Working Capital Per Employee | 7.8M | |
| Working Capital Per Executive | 2.2M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLight Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for BioLight Stock analysis
When running BioLight Life's price analysis, check to measure BioLight Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLight Life is operating at the current time. Most of BioLight Life's value examination focuses on studying past and present price action to predict the probability of BioLight Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLight Life's price. Additionally, you may evaluate how the addition of BioLight Life to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |